L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1

[1]  J. Rich,et al.  Potential therapeutic implications of cancer stem cells in glioblastoma. , 2010, Biochemical pharmacology.

[2]  P. Altevogt,et al.  Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma. , 2010, Cancer research.

[3]  C. Josenhans,et al.  Myc Is Required for Activation of the ATM-Dependent Checkpoints in Response to DNA Damage , 2010, PloS one.

[4]  B. Sullenger,et al.  Notch Promotes Radioresistance of Glioma Stem Cells , 2009, Stem cells.

[5]  U. Weidle,et al.  L1-CAM as a target for treatment of cancer with monoclonal antibodies. , 2009, Anticancer research.

[6]  T. Yawata,et al.  Enhanced MDR1 Expression and Chemoresistance of Cancer Stem Cells Derived from Glioblastoma , 2009, Cancer investigation.

[7]  R. McLendon,et al.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype , 2009, Cell cycle.

[8]  John A. Tainer,et al.  Nbs1 Flexibly Tethers Ctp1 and Mre11-Rad50 to Coordinate DNA Double-Strand Break Processing and Repair , 2009, Cell.

[9]  Justin C. Grindley,et al.  Tumour-initiating cells: challenges and opportunities for anticancer drug discovery , 2009, Nature Reviews Drug Discovery.

[10]  A. Ben-Ze'ev,et al.  L1 cell adhesion molecule (L1CAM) in invasive tumors. , 2009, Cancer letters.

[11]  R. Kerbel,et al.  Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. , 2009, Cancer research.

[12]  P. F. Siesser,et al.  L1 cell adhesion molecules as regulators of tumor cell invasiveness , 2009 .

[13]  E. Fischer,et al.  The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor. , 2009, The international journal of biochemistry & cell biology.

[14]  G. Fròsina.  DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy , 2009, Molecular Cancer Research.

[15]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[16]  P. Altevogt,et al.  Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. , 2009, Cancer research.

[17]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[18]  Khalid Shah,et al.  Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. , 2009, Cancer research.

[19]  D. Roth,et al.  Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates. , 2009, Molecular cell.

[20]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[21]  M. Yaffe,et al.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. , 2009, Current opinion in cell biology.

[22]  P. Altevogt,et al.  Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/γ-secretase activity , 2009, The Biochemical journal.

[23]  M. Verdier,et al.  Cancer stem cells from human glioma cell line are resistant to Fas-induced apoptosis. , 2009, International journal of oncology.

[24]  F. Stewart,et al.  Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells. , 2009, International journal of radiation oncology, biology, physics.

[25]  P. Altevogt,et al.  alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma. , 2009, International journal of oncology.

[26]  A. Ben-Ze'ev,et al.  L1-CAM in cancerous tissues , 2008 .

[27]  R. McLendon,et al.  Targeting cancer stem cells through L1CAM suppresses glioma growth. , 2008, Cancer research.

[28]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[29]  I. Mook‐Jung,et al.  DNA damage-inducing agents elicit γ-secretase activation mediated by oxidative stress , 2008, Cell Death and Differentiation.

[30]  R. Arceci.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2008 .

[31]  A. Ben-Ze'ev,et al.  L1-CAM in cancerous tissues. , 2008, Expert opinion on biological therapy.

[32]  J Wade Harper,et al.  The DNA damage response: ten years after. , 2007, Molecular cell.

[33]  L. Chin,et al.  Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.

[34]  P. Altevogt,et al.  The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies , 2007, Oncogene.

[35]  R. Gilbertson,et al.  Making a tumour's bed: glioblastoma stem cells and the vascular niche , 2007, Nature Reviews Cancer.

[36]  D. Notterman,et al.  Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. , 2007, Cancer research.

[37]  Xu-Dong Zhu,et al.  MRE11–RAD50–NBS1 and ATM function as co-mediators of TRF1 in telomere length control , 2007, Nature Structural &Molecular Biology.

[38]  John A Tainer,et al.  Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template. , 2007, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[39]  R. Monnat,et al.  Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair , 2007, Nature Cell Biology.

[40]  P. Altevogt,et al.  Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells , 2007, Oncogene.

[41]  J. Bartek,et al.  DNA damage checkpoints: from initiation to recovery or adaptation. , 2007, Current opinion in cell biology.

[42]  P. Altevogt,et al.  L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. , 2007, Gynecologic oncology.

[43]  W. Woodward,et al.  WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells , 2007, Proceedings of the National Academy of Sciences.

[44]  G. Broggi,et al.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells , 2006, Nature.

[45]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[46]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[47]  Qiulian Wu,et al.  Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. , 2006, Cancer research.

[48]  P. Altevogt,et al.  The adhesion molecule L1 (CD171) promotes melanoma progression , 2006, International journal of cancer.

[49]  L. Ricci-Vitiani,et al.  Chemotherapy resistance of glioblastoma stem cells , 2006, Cell Death and Differentiation.

[50]  Angelo L. Vescovi,et al.  Brain tumour stem cells , 2006, Nature Reviews Cancer.

[51]  J. Shay,et al.  The involvement of the Mre11/Rad50/Nbs1 complex in the generation of G‐overhangs at human telomeres , 2006, EMBO reports.

[52]  P. Altevogt,et al.  Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. , 2006, Cancer research.

[53]  M. Schachner,et al.  Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration , 2006, Nature Neuroscience.

[54]  C. Blobel,et al.  L1 Is Sequentially Processed by Two Differently Activated Metalloproteases and Presenilin/γ-Secretase and Regulates Neural Cell Adhesion, Cell Migration, and Neurite Outgrowth , 2005, Molecular and Cellular Biology.

[55]  Ji-Hoon Lee,et al.  ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex , 2005, Science.

[56]  Stephen P. Jackson,et al.  Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage , 2005, Nature.

[57]  P. Altevogt,et al.  L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers , 2005, The Journal of cell biology.

[58]  T. Yoshimine,et al.  Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion , 2005, Journal of Clinical Pathology.

[59]  Jiri Bartek,et al.  Cell-cycle checkpoints and cancer , 2004, Nature.

[60]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[61]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[62]  J. Bartek,et al.  Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. , 2004, DNA repair.

[63]  Daniel H. Geschwind,et al.  Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[64]  P. Altevogt,et al.  L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas , 2003, The Lancet.

[65]  R. Bonner,et al.  Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks , 2003, Nature Cell Biology.

[66]  Kou-Juey Wu,et al.  c-Myc Directly Regulates the Transcription of the NBS1 Gene Involved in DNA Double-strand Break Repair * , 2003, Journal of Biological Chemistry.

[67]  Jiri Bartek,et al.  Chk1 and Chk2 kinases in checkpoint control and cancer. , 2003, Cancer cell.

[68]  Y. Shiloh.  ATM and related protein kinases: safeguarding genome integrity , 2003, Nature Reviews Cancer.

[69]  S. Jackson,et al.  The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling , 2002, Nature Reviews Molecular Cell Biology.

[70]  R. Abraham.  Cell cycle checkpoint signaling through the ATM and ATR kinases. , 2001, Genes & development.

[71]  J. Gärtner,et al.  Genetic and clinical aspects of X‐linked hydrocephalus (L1 disease): Mutations in the L1CAM gene , 2001, Human mutation.

[72]  Xiao-Fan Wang,et al.  ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses , 2001, Nature.

[73]  T. Ohnishi,et al.  Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion. , 1996, Cancer research.

[74]  R. Tice,et al.  The single cell gel electrophoresis/comet assay: a potential tool for detecting radiation-induced DNA damage in humans. , 1995, Stem cells.